AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FDA Reviews Application for Intranasal Vaccine.(Brief Article)
2001 JAN 17 - (NewsRx.com & NewsRx.net) -- Aviron (AVIR) announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for FluMist, an investigational intranasal influenza vaccine.
On October 31, 2000, Aviron submitted a BLA to the FDA seeking U.S. licensure of FluMist to prevent influenza in healthy children and healthy adults. The decision by the FDA to accept the submission for review was the next step in the regulatory process. If approved, FluMist would be the first flu vaccine delivered as a nasal mist to be commercially available in the U.S.
The BLA acceptance triggers a $15.5 million payment to Aviron from ...
- Flu shot shortage could help nasal spray FluMist in the short term.
- Newspaper article from: Vaccine Weekly December 31, 2003 700+ words
...Administration did not approve FluMist for children under 5 years...out of an agreement to stock FluMist in its pharmacies. MedImmune...25 mail-in rebate for FluMist customers to try to cut the...This article was prepared by Vaccine Weekly editors from staff and other...
- FluMist producer announces expanded delivery.
- Newspaper article from: Vaccine Weekly November 24, 2004 700+ words
...increasing its planned delivery of FluMist (Influenza Virus Vaccine...on Immunization Practices. FluMist was approved by the FDA in...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- FluMist maker announces plan to achieve $2 billion in revenues by 2009.
- Newspaper article from: Vaccine Weekly April 7, 2004 700+ words
...refrigerator-stable version of FluMist (CAIV-T) in the United States. In 2004, FluMist-related revenue is currently...efforts on developing FluMist into a superior influenza...article was prepared by Vaccine Weekly editors from staff and...
- FluMist to be donated to public health agencies.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...doctors offices that distribute FluMist. He said the donation clears...the hope they will remember FluMist next flu season. Flu vaccines...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- FluMist maker reports record revenues and earnings for the first quarter.
- Newspaper article from: Vaccine Weekly May 19, 2004 700+ words
...down of the 2004/2005 FluMist seasonal inventory produced...including Vitaxin, Numax, FluMist, and CAIV-T. Selling...the costs for manufacturing FluMist prior to the vaccine's approval...This article was prepared by Vaccine Weekly editors from staff and other...
- CDC to include FluMist in vaccines for children program.
- Newspaper article from: Vaccine Weekly December 1, 2004 700+ words
...healthy children. Offering FluMist through this program as an...year - and deaths can occur. FluMist is the first live, attenuated...This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx...
- FDA advisory committee recommends approval for FluMist.(Brief Article)
- Newspaper article from: Vaccine Weekly January 22, 2003 700+ words
...nose/nasal congestion. "FluMist is cutting-edge technology...Wyeth Pharmaceuticals. "FluMist, with its intranasal administration...15 billion. If and when FluMist is approved for marketing...This article was prepared by Vaccine Weekly editors from staff and other...
- MedImmune Gets FluMist Rights In Agreement With Aviron.(Brief Article)
- Newspaper article from: Vaccine Weekly January 9, 2002 700+ words
...Aviron, which licensed the FluMist technology from the University...said its goal is to launch FluMist in 2002, with sales goals...billion within five years. FluMist uses a live but weakened virus...This article was prepared by Vaccine Weekly editors from staff and other...